Article
The effects of co-morbidities on blood transcriptomes in tuberculosis patients before and during treatment
2018-01-01
Abstract excerpt
The blood transcriptome in tuberculosis (TB) has been well described, it is distinct from healthy controls and other diseases, and is being developed as a biomarker for risk of disease progression, disease severity and treatment response. But TB patients, especially those from high TB-burden countries, often have comorbidities, so the described transcriptomic signature may not be an accurate representation of a ty...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0c725d7d-06a1-5a53-84a3-6e57082c7c02
- DOI
- 10.17037/pubs.04648205
